Diabetes

Jardiance Met 12.5/500® Empaglifozin and Metformin Tablets
Empaglifozin12.5mg + Metformin 500mg
- Composition
- Empaglifozin12.5mg + Metformin 500mg
- Dosage form
- Tablet
- Pack size
- Strip of 10 Tablet
- Manufacturer
- Boehringer Ingelheim
- Also known as
- Jardience
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Jardiance Met 12.5/500 contains Empagliflozin 12.5 mg and Metformin 500 mg. It is used to improve blood sugar control in adults with type 2 diabetes mellitus. Empagliflozin helps the kidneys remove excess glucose through urine, while metformin reduces glucose production in the liver and improves insulin sensitivity,
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Diabetes
Diabetes
Diabetes
Diabetes
